Skip to content
Top Menu
  • Log In
  • Register
  • Facebook
  • Twitter
  • LinkedIn
MyChesCo

MyChesCo

Chester County News and Community Website

  • Communities
    • Avondale
    • Berwyn
    • Coatesville
    • Cochranville
    • Devon
    • Downingtown
    • Exton
    • Honey Brook
    • Kennett Square
    • Malvern
    • Oxford
    • Paoli
    • Parkesburg
    • Phoenixville
    • Spring City
    • Toughkenamon
    • West Chester
    • West Grove
  • Education
    • Chester County Intermediate Unit
    • School Districts
      • Avon Grove School District
      • Coatesville Area School District
      • Downingtown Area School District
      • Great Valley School District
      • Kennett Consolidated School District
      • Octorara Area School District
      • Owen J. Roberts School District
      • Oxford Area School District
      • Phoenixville Area School District
      • Spring-Ford Area School District
      • Tredyffrin-Easttown School District
      • Twin Valley School District
      • Unionville-Chadds Ford School District
      • West Chester Area School District
    • Charter Schools
    • Independent Schools
    • Colleges and Universities
    • Chester County Library System
  • News
    • Traffic
    • Weather
    • Business
    • Health / Medical
    • National
    • Pennsylvania
    • Sports
  • Entertainment
  • Lifestyle
  • Tools
    • Members
    • Groups
    • Submit an Article
    • Contact Us
    • Signup for Newsletter
    • Contests and Giveaways
    • Gas Prices
    • Register
    • Log In
  • About
    • MyChesCo
    • Writing for Us
    • Advertising with Us
    • Contacting Us
    • Citizen Journalism
    • Submitting Articles
    • Starting a Group
    • How to Support Us
    • Terms of Service
    • Privacy Policy
    • DMCA Policy
    • Sponsored Content
    • Affiliate Disclaimer
  • Shop

Clinical data management

Virpax Pharmaceuticals
Business

Virpax Announces MMS019 Manufacturing and Supply Agreement

August 30, 2021August 29, 2021 - by MyChesCo

BERWYN, PA — Virpax® Pharmaceuticals, Inc. (NASDAQ: VRPX) announced that it recently entered into a commercial manufacturing and supply agreement with Seqens, an integrated global leader in pharmaceutical solutions with …

Virpax Announces MMS019 Manufacturing and Supply Agreement Read More

FDA Approves New Therapy for Rare Disease Affecting Optic Nerve, Spinal Cord
Cancer / National

FDA Provides Guidance on Measuring Patient-Reported Outcomes in Cancer Clinical Trials

June 9, 2021June 9, 2021 - by MyChesCo

WASHINGTON, D.C. — The following quote is attributed to Richard Pazdur, M.D., director of the FDA’s Oncology Center of Excellence and acting director of the Office of Oncologic Diseases in …

FDA Provides Guidance on Measuring Patient-Reported Outcomes in Cancer Clinical Trials Read More

Trending News

  • PECO Utility Improvement Begins Next Week on Manor Avenue in Downingtown Borough
  • Republicans Criticize New USDA School Nutrition Standards
  • Casey, Fetterman Announce $340 Million for Philadelphia Water Infrastructure, Lead Pipe Replacement
  • Where to Watch the Big Game: The 10 Best Sports Bars in Chester County
  • Unionville High School PTO Used Book Sale – Find Out What Treasures Await!

Subscribe for Updates

Follow Us

  • Facebook
  • Twitter
  • LinkedIn
  • Google
  • RSS Feed

Tools

  • Members
  • Newsletter
  • Events
  • Groups
  • Guest Articles
  • Coupon Center
  • Gas Prices
  • Log In
  • Register

About Us

  • About MyChesCo
  • Advertise
  • Contact Us
  • Support Us
  • Write for Us
  • Terms of Service
  • Privacy Policy
  • DMCA Policy
  • Affiliate Disclaimer

Recommended Reading

football

Don’t Get Scammed! PA Office of Attorney General Warns of Super Bowl LVII Fraud

February 4, 2023February 4, 2023

Pastor Bill Devlin and his wife

Reverend Dr. William Devlin Receives Lifetime Achievement Award from The White House

February 4, 2023February 3, 2023

WSFS CARES

WSFS CARES Foundation Provided More Than $2.4 Million in Charitable Grants and Contributions in 2022

February 3, 2023February 3, 2023

Copyright © 2023 MyChesCo.